Evidence map›Paper›PMID 34194774›Full record

ArticleClinical case reports2021

Primary breast lymphoma initially diagnosed as invasive ductal carcinoma: A case report.

Natsuki Uenaka, Shinya Yamamoto, Seiya Sato, Takamichi Kudo, Shoko Adachi, Kazutaka Narui, Mikiko Tanabe, Akimitsu Yamada, Takashi Ishikawa, Itaru Endo

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Rare Breast Cancers Review.Healthcare (Basel, Switzerland) · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Natsuki UenakaDepartment of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0002-8974-9231
Shinya YamamotoDepartment of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.ORCID https://orcid.org/0000-0002-8083-5387
Seiya SatoDepartment of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Takamichi KudoDepartment of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Shoko AdachiDepartment of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Kazutaka NaruiDepartment of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Mikiko TanabeDepartment of Pathology Yokohama City University Medical Center Yokohama Japan.
Akimitsu YamadaDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Takashi IshikawaDepartment of Breast Surgery and Oncology Tokyo Medical University Shinjuku-ku Japan.
Itaru EndoDepartment of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A malignant tumor in the breast may not be conclusive of breast cancer. It is important to keep the possibility of primary breast lymphoma in rare scenarios. For the diagnosis of primary breast lymphoma, immunohistochemical staining is necessary.

Indexed as

breastimmunohistochemical staininglymphoma

Identifiers

PMID34194774
PMCPMC8222742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.